期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
Construction and Exploration of Ideological and Political Education in Crop Breeding Course
1
作者 Hui LI fanjun zeng Yinghong TANG 《Asian Agricultural Research》 2021年第2期58-60,共3页
In order to start a new situation for the development of higher education in China,and to achieve the goal of educating people through the whole process and all-round education in colleges and universities,this paper ... In order to start a new situation for the development of higher education in China,and to achieve the goal of educating people through the whole process and all-round education in colleges and universities,this paper takes Crop Breeding Course as an example,from the characteristics of the curriculum,the history of crop breeding and the ideological and political elements of professional courses,explored the curriculum construction in the aspects of excavation,and summarized the effects of the ideological and political construction of Crop Breeding Course. 展开更多
关键词 Crop Breeding Course Ideological and political education in courses AGRONOMY
下载PDF
A homologous and molecular dual-targeted biomimetic nanocarrier for EGFR-related non-small cell lung cancer therapy 被引量:1
2
作者 Bin Xu fanjun zeng +15 位作者 Jialong Deng Lintong Yao Shengbo Liu Hengliang Hou Yucheng Huang Hongyuan Zhu Shaowei Wu Qiaxuan Li Weijie Zhan Hongrui Qiu Huili Wang Yundong Li Xianzhu Yang Ziyang Cao Yu Zhang Haiyu Zhou 《Bioactive Materials》 SCIE CSCD 2023年第9期337-347,共11页
The abnormal activation of epidermal growth factor receptor(EGFR)drives the development of non-small cell lung cancer(NSCLC).The EGFR-targeting tyrosine kinase inhibitor osimertinib is frequently used to clinically tr... The abnormal activation of epidermal growth factor receptor(EGFR)drives the development of non-small cell lung cancer(NSCLC).The EGFR-targeting tyrosine kinase inhibitor osimertinib is frequently used to clinically treat NSCLC and exhibits marked efficacy in patients with NSCLC who have an EGFR mutation.However,free osimertinib administration exhibits an inadequate response in vivo,with only~3%patients demonstrating a complete clinical response.Consequently,we designed a biomimetic nanoparticle(CMNP^(@Osi))comprising a polymeric nanoparticle core and tumor cell-derived membrane-coated shell that combines membrane-mediated homologous and molecular targeting for targeted drug delivery,thereby supporting a dual-target strategy for enhancing osimertinib efficacy.After intravenous injection,CMNP^(@Osi)accumulates at tumor sites and displays enhanced uptake into cancer cells based on homologous targeting.Osimertinib is subsequently released into the cytoplasm,where it suppresses the phosphorylation of upstream EGFR and the downstream AKT signaling pathway and inhibits the proliferation of NSCLC cells.Thus,this dual-targeting strategy using a biomimetic nanocarrier can enhance molecular-targeted drug delivery and improve clinical efficacy. 展开更多
关键词 Biomimetic nanoparticles Membrane targeting EGFR mutation Tyrosine kinase inhibitor Intracellular drug delivery Clinical efficacy Non-small cell lung cancer
原文传递
Successful kidney transplantation in highly sensitized patients
3
作者 Weijie ZHANG Dong CHEN +6 位作者 Zhishui CHEN fanjun zeng Changsheng MING Zhengbin LIN Ping ZHOU Gang CHEN Xiaoping CHEN 《Frontiers of Medicine》 SCIE CSCD 2011年第1期80-85,共6页
Highly sensitized patients experience an increased number of rejection episodes and have poorer graft survival rates;hence,sensitization is a significant barrier to both access to and the success of organ transplantat... Highly sensitized patients experience an increased number of rejection episodes and have poorer graft survival rates;hence,sensitization is a significant barrier to both access to and the success of organ transplantation.This study reports our experience in kidney transplantation in highly sensitized patients.Fourteen patients with sensitization or high levels of panelreactive antibodies(PRA)were studied.All patients were desensitized with pre-transplant intravenous immunoglobulin(IVIG)/plasmapheresis(PP)with or without rituximab and thymoglobulin induction therapy,combined with a Prograf/MMF/Pred immunosuppressive regimen.Of 14 patients,10 showed good graft functions without acute rejection(AR)episodes.Acute cellular rejection in two patients was reversed by methylprednisolone.Two patients underwent antibody-mediated rejection;one was treated with PP/IVIG successfully,whereas the other lost graft functions due to the de novo production of donor-specific antibodies(DSA).Graft functions were stable,and there were no AR episodes in other patients.Conclusively,desensitization using PP/IVIG with or without rituximab increases the likelihood of successful live-donor kidney transplantation in sensitized recipients. 展开更多
关键词 Kidney transplantation DESENSITIZATION
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部